Compare Crown Castle International Corp (CCI) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crown Castle International Corp vs Medpace Holdings Inc — how do they compare? Crown Castle International Corp trades at $73.8 (market cap $31.33B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Crown Castle International Corp is the larger of the two by market cap, and Crown Castle International Corp pays a 5.77% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| CCI | MEDP | |
|---|---|---|
Market Cap | $31.33B | $16.90B |
Sector | Real Estate | Technology |
52-Week High | $103.79 | $620.59 |
52-Week Low | $73.61 | $393.42 |
Enterprise Value | $53.69B | $16.52B |
Dividend Yield | 5.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
